1. Home
  2. CWH vs URGN Comparison

CWH vs URGN Comparison

Compare CWH & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camping World Holdings Inc.

CWH

Camping World Holdings Inc.

HOLD

Current Price

$6.58

Market Cap

1.1B

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$18.94

Market Cap

922.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWH
URGN
Founded
1966
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
922.1M
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
CWH
URGN
Price
$6.58
$18.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
$15.89
$29.29
AVG Volume (30 Days)
3.2M
716.7K
Earning Date
04-28-2026
03-02-2026
Dividend Yield
7.32%
N/A
EPS Growth
N/A
N/A
EPS
3.99
N/A
Revenue
$4,792,017,000.00
$1,128,000.00
Revenue This Year
$4.63
$127.17
Revenue Next Year
$5.85
$73.82
P/E Ratio
$1.71
N/A
Revenue Growth
11.83
N/A
52 Week Low
$5.70
$3.42
52 Week High
$19.64
$30.00

Technical Indicators

Market Signals
Indicator
CWH
URGN
Relative Strength Index (RSI) 36.82 50.93
Support Level $5.70 $18.37
Resistance Level $18.18 $20.44
Average True Range (ATR) 0.43 0.93
MACD 0.23 0.09
Stochastic Oscillator 71.43 87.80

Price Performance

Historical Comparison
CWH
URGN

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Share on Social Networks: